AGP Executive Report
Last update: 2 hours agoHemp THC Policy Fight: A multibillion-dollar hemp THC market is bracing for a looming federal ban after Congress moved to close a loophole, pushing the effective date from Nov. 12 to Dec. 11—giving lawmakers more time to decide whether to regulate instead of eliminate. M&A Watch: Curaleaf sweetened its hostile bid for Edmonton’s Aurora Cannabis to $5 per Aurora share (up from $4), signaling a push to win over shareholders and accelerate a merger. Medical Cannabis Research: FDA is seeking public input on early-stage clinical trial design for ibogaine, aiming to balance potential therapies with serious safety concerns. Science & Safety: Northwestern researchers identified brain neurons tied to anxiety after cannabinoid exposure in mice, offering a possible explanation for “good trip” turning bad under stress. Veterans & Wellness: Cannatrol’s Cool Cure Limited Edition program added Operation Green Healing as its exclusive veterans nonprofit partner, funding outreach via sales. Public Health/Compliance: A new VA records-based op-ed argues rising cannabis use disorder diagnoses among veterans may be shaped by changing diagnostic rules, not just behavior. Regulatory/Enforcement: Police in Estonia say QR stickers near schools are steering users to online drug shops, raising fears about access by minors.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
